On Monday, Aldeyra Therapeutics Inc (NASDAQ: ALDX) was 5.32% up from the session before settling in for the closing price of $4.7. A 52-week range for ALDX has been $1.14 – $7.20.
A company in the Healthcare sector has jumped its sales by 15.99% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 34.84%. With a float of $58.21 million, this company’s outstanding shares have now reached $60.16 million.
Aldeyra Therapeutics Inc (ALDX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Aldeyra Therapeutics Inc stocks. The insider ownership of Aldeyra Therapeutics Inc is 3.25%, while institutional ownership is 65.69%. The most recent insider transaction that took place on Aug 13 ’25, was worth 13,250. In this transaction Principal Financial Officer of this company bought 2,500 shares at a rate of $5.30, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Development Officer sold 22,073 for $5.15, making the entire transaction worth $113,713. This insider now owns 221,799 shares in total.
Aldeyra Therapeutics Inc (ALDX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.27 earnings per share (EPS) during the time that was less than consensus figure (set at -0.22) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.84% per share during the next fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
You can see what Aldeyra Therapeutics Inc (ALDX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.72, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.13 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.23 million. That was better than the volume of 1.05 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 16.49%.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 37.02%, which indicates a significant increase from 27.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was higher than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.19, while its 200-day Moving Average is $4.55. However, in the short run, Aldeyra Therapeutics Inc’s stock first resistance to watch stands at $5.08. Second resistance stands at $5.20. The third major resistance level sits at $5.37. If the price goes on to break the first support level at $4.79, it is likely to go to the next support level at $4.62. Assuming the price breaks the second support level, the third support level stands at $4.50.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Key Stats
There are 60,163K outstanding shares of the company, which has a market capitalization of 297.81 million. As of now, sales total 0 K while income totals -55,850 K. Its latest quarter income was 0 K while its last quarter net income were -7,690 K.
